Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Nov;162(5):e285-e287.
doi: 10.1016/j.chest.2022.08.2204.

Response

Wesley H Self  1 , Allison P Wheeler  2 , James D Chappell  3 , Isaac Thomsen  3 , Jill M Pulley  4 , Jillian P Rhoads  4 , Gordon R Bernard  5 , Todd W Rice  5
Affiliations
Comment

Response

Wesley H Self et al. Chest. 2022 Nov.
No abstract available

PubMed Disclaimer

Comment on

  • Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial.
    Self WH, Wheeler AP, Stewart TG, Schrager H, Mallada J, Thomas CB, Cataldo VD, O'Neal HR Jr, Shapiro NI, Higgins C, Ginde AA, Chauhan L, Johnson NJ, Henning DJ, Jaiswal SJ, Mammen MJ, Harris ES, Pannu SR, Laguio-Vila M, El Atrouni W, de Wit M, Hoda D, Cohn CS, McWilliams C, Shanholtz C, Jones AE, Raval JS, Mucha S, Ipe TS, Qiao X, Schrantz SJ, Shenoy A, Fremont RD, Brady EJ, Carnahan RH, Chappell JD, Crowe JE Jr, Denison MR, Gilchuk P, Stevens LJ, Sutton RE, Thomsen I, Yoder SM, Bistran-Hall AJ, Casey JD, Lindsell CJ, Wang L, Pulley JM, Rhoads JP, Bernard GR, Rice TW; Passive Immunity Trial for Our Nation (PassITON) Investigators. Self WH, et al. Chest. 2022 Nov;162(5):982-994. doi: 10.1016/j.chest.2022.06.029. Epub 2022 Jul 1. Chest. 2022. PMID: 35780813 Free PMC article. Clinical Trial.
  • Limitations on PassItOn Design and Execution Should Temper Negative Conclusions.
    Shoham S, Focosi D. Shoham S, et al. Chest. 2022 Nov;162(5):e282-e283. doi: 10.1016/j.chest.2022.07.030. Chest. 2022. PMID: 36344141 Free PMC article. No abstract available.
  • Late Treatment for COVID-19 With Convalescent Plasma.
    Senefeld JW, Paneth NS, Carter RE, Wright RS, Fairweather D, Bruno KA, Joyner MJ. Senefeld JW, et al. Chest. 2022 Nov;162(5):e283-e284. doi: 10.1016/j.chest.2022.07.029. Chest. 2022. PMID: 36344142 Free PMC article. No abstract available.
  • COVID-19 Convalescent Plasma and Concomitant Therapies in PassITON.
    Casadevall A, Henderson JP. Casadevall A, et al. Chest. 2022 Nov;162(5):e284-e285. doi: 10.1016/j.chest.2022.07.028. Chest. 2022. PMID: 36344143 Free PMC article. No abstract available.

References

    1. Self WH, Wheeler AP, Stewart TG, et al. Neutralizing COVID-19 convalescent plasma in adults hospitalized with COVID-19: a blinded randomized placebo-controlled trial. Chest. 2022;162(5):982–994. - PMC - PubMed
    1. Gilchuk P., Thomsen I., Yoder S., et al. Standardized two-step testing of antibody activity in COVID-19 convalescent plasma. iScience. 2022;25(1):103602. - PMC - PubMed
    1. Self W.H., Stewart T.G., Wheeler A.P., et al. Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults. Trials. 2021;22(1):221. - PMC - PubMed
    1. RECOVERY Collaborative Group Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. Lancet. 2021;397(10289):2049–2059. - PMC - PubMed
    1. Writing Committee for the REMAP-CAP Investigators. Estcourt L.J., Turgeon A.F., et al. Effect of convalescent plasma on organ support-free days in critically ill patients with COVID-19: a randomized clinical trial. JAMA. 2021;326(17):1690–1702. - PMC - PubMed